Other Clinical Trial - Perinatal Outcomes in Umbilical Cord NCT03504969

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Details — Status: Not yet recruiting

Umbilical Cord Entanglement and Perinatal Outcomes.

Umbilical Cord Entanglement and Perinatal Outcomes neonatal outcomes and the effect on mode of delivery

Recruitment information / eligibility
Status	Not yet recruiting
Enrollment	201
Est. completion date	January 1, 2020
Est. primary completion date	January 1, 2020
Accepts healthy volunteers	Accepts Healthy Volunteers
Gender	Female
Age group	N/A and older
Eligibility	Inclusion Criteria: - all vaginal deliveries with or without Umbilical Cord Entanglement Exclusion Criteria: - multible pregnancy

Locations
Country	Name	City	State
n/a

Sponsors *(1)*
Lead Sponsor	Collaborator
Assiut University

Outcome
Type	Measure	Description	Time frame	Safety issue
Primary	perinatal outcomes	number of neonates with bad Apgar score	one year
Secondary	delivery outcome	number of vaginal deliveries switch to S.C	one year